Catalyst Capital Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Catalyst Capital Advisors LLC

$4.41 Billion
Q3 2024

A detailed history of Catalyst Capital Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 84 shares of REGN stock, worth $62,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 104 19.23%

Holding current value

$62,160

Previous $109,000 19.27%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$1024.09 - $1201.76 $20,481 - $24,035	-20 Reduced 19.23%	84 $88,000
Q2 2024 Jul 25, 2024	BUY	$883.2 - $1071.19 $2,649 - $3,213	3 Added 2.97%	104 $109,000
Q1 2024 Apr 24, 2024	BUY	$902.69 - $993.35 $902 - $993	1 Added 1.0%	101 $97,000
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $15,503 - $17,634	20 Added 25.0%	100 $87,000
Q3 2023 Nov 09, 2023	BUY	$692.45 - $844.37 $14,541 - $17,731	21 Added 35.59%	80 $65,000
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $700 - $830	1 Added 1.72%	59 $42,000
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $17,692 - $21,501	-26 Reduced 30.95%	58 $47,000
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $705 - $766	-1 Reduced 1.18%	84 $61,000
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $31,255 - $42,113	-57 Reduced 40.14%	85 $50,000
Q1 2022 May 10, 2022	BUY	$595.12 - $698.43 $49,990 - $58,668	84 Added 144.83%	142 $99,000
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $16,847 - $20,800	-31 Reduced 34.83%	58 $37,000
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $13,776 - $16,343	24 Added 36.92%	89 $54,000
Q2 2021 Aug 06, 2021	BUY	$472.8 - $558.54 $1,418 - $1,675	3 Added 4.84%	65 $36,000
Q1 2021 May 10, 2021	SELL	$446.73 - $548.2 $5,360 - $6,578	-12 Reduced 16.22%	62 $29,000
Q4 2020 Feb 05, 2021	BUY	$478.3 - $607.98 $35,394 - $44,990	74 New	74 $36,000
Q2 2019 Aug 08, 2019	SELL	$299.6 - $414.82 $29,960 - $41,482	-100 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $37,208 - $43,957	100 New	100 $41,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.

Account

Catalyst Capital Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History